Provided by Tiger Fintech (Singapore) Pte. Ltd.

Miragen Therapeutics, Inc.

23.01
0.0000
Volume:- -
Turnover:- -
Market Cap:89.93M
PE:-2.38
High:23.01
Open:23.01
Low:23.01
Close:23.01
Loading ...

BRIEF-Xencor Inc Reports 7.6% Passive Stake In Miragen Therapeutics

Reuters
·
12 Jan 2021

Oppenheimer: These 3 Stocks Could Spike Over 80%

TipRanks
·
08 Jan 2021

BRIEF-Ally Bridge Medalpha Master Fund Lp Reports 9.99% Passive Stake In Miragen Therapeutics As Of Dec 31, 2020 - SEC Filing

Reuters
·
07 Jan 2021

BRIEF-Miragen Therapeutics Inc Files Prospectus Relating To Resale Of Up To 26.7 Mln Shares Of Common Stock By Selling Shareholders - SEC Filing

Reuters
·
24 Dec 2020

BRIEF-RA Capital Management Reports 11.6% Passive Stake In Miragen Therapeutics Inc As Of December 7 - SEC Filing

Reuters
·
18 Dec 2020

miRagen Enters into License Agreement with Xencor for use of Xtend™ Antibody Technology for Investigational Antibodies to Treat Thyroid Eye Disease

GlobeNewswire
·
17 Dec 2020

BRIEF-Miragen Therapeutics Inc - Files For Stock Shelf Of Upto 26.7 Mln Shares By Selling Stockholders - SEC Filing

Reuters
·
16 Dec 2020

Mid-Afternoon Market Update: Nasdaq Turns Positive; Cinedigm Shares Slide

Benzinga
·
18 Nov 2020

BRIEF-Miragen Receives Nasdaq Letter Notifying Co That It Has Regained Compliance With Certain Listing Rule

Reuters
·
14 Nov 2020

The Daily Biotech Pulse: Five Prime Skyrockets, Multiple Conference Presentations On Tap

Benzinga
·
11 Nov 2020

BRIEF-Miragen Posts Q3 Loss Per Share $0.10

Reuters
·
11 Nov 2020

Miragen Therapeutics Q3 EPS $(0.10) Up From $(0.36) YoY

Benzinga
·
11 Nov 2020

miRagen Reports Third Quarter 2020 Financial Results and Provides Corporate Updates

GlobeNewswire
·
11 Nov 2020

Arena (ARNA) Q3 Earnings Top, Stock Down on Eczema Study Data

Zacks
·
10 Nov 2020

BRIEF-Biotechnology Value Fund Lp Reports 9.9% Passive Stake In Miragen Therapeutics Inc

Reuters
·
10 Nov 2020

Iovance (IOVA) Q3 Earnings Beat Estimates, Pipeline in Focus

Zacks
·
09 Nov 2020

Sarepta (SRPT) Q3 Loss Widens Y/Y, Revenues Beat Estimates

Zacks
·
06 Nov 2020

Clovis (CLVS) Q3 Earnings Top, Sales Show Coronavirus Impact

Zacks
·
06 Nov 2020